ARS Pharmaceuticals Inc. (SPRY) PE Ratio
ARS Pharmaceuticals Inc. (SPRY) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.
PE Ratio Data
| Period | PE Ratio |
|---|---|
| 2021-12-31 | -3.20 |
| 2022-12-31 | -9.41 |
| 2023-12-31 | -14.37 |
| 2024-12-31 | 102.37 |
Get ARS Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =PERatio("SPRY")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SPRY | $8.19 | +0.49% | 0.79M |
| 3 | ||||
| 4 | ||||
| 5 |